Penn Capital Management Co. Inc. grew its holdings in shares of Cryolife Inc (NYSE:CRY) by 39.2% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 104,592 shares of the medical equipment provider’s stock after acquiring an additional 29,472 shares during the quarter. Penn Capital Management Co. Inc.’s holdings in Cryolife were worth $2,003,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also bought and sold shares of the company. BlackRock Inc. increased its stake in shares of Cryolife by 4.9% during the fourth quarter. BlackRock Inc. now owns 4,344,104 shares of the medical equipment provider’s stock valued at $83,188,000 after buying an additional 204,843 shares during the period. Dimensional Fund Advisors LP increased its stake in shares of Cryolife by 1.8% during the third quarter. Dimensional Fund Advisors LP now owns 1,994,820 shares of the medical equipment provider’s stock valued at $45,282,000 after buying an additional 34,599 shares during the period. Vanguard Group Inc. increased its stake in shares of Cryolife by 6.6% during the second quarter. Vanguard Group Inc. now owns 1,658,646 shares of the medical equipment provider’s stock valued at $33,090,000 after buying an additional 102,540 shares during the period. Macquarie Group Ltd. grew its stake in Cryolife by 16.0% in the third quarter. Macquarie Group Ltd. now owns 1,609,284 shares of the medical equipment provider’s stock worth $36,531,000 after purchasing an additional 221,574 shares during the period. Finally, Northern Trust Corp grew its stake in Cryolife by 7.4% in the second quarter. Northern Trust Corp now owns 1,171,769 shares of the medical equipment provider’s stock worth $23,377,000 after purchasing an additional 81,090 shares during the period. 73.71% of the stock is currently owned by hedge funds and other institutional investors.
CRY has been the topic of several recent research reports. Zacks Investment Research raised Cryolife from a “sell” rating to a “hold” rating in a research note on Tuesday, January 16th. Northland Securities reaffirmed a “buy” rating and issued a $23.50 price target on shares of Cryolife in a research note on Monday, November 13th. TheStreet cut Cryolife from a “b” rating to a “c+” rating in a research note on Monday, October 30th. Finally, Canaccord Genuity reaffirmed a “buy” rating and issued a $25.00 price target on shares of Cryolife in a research note on Wednesday, January 3rd. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. Cryolife currently has a consensus rating of “Hold” and a consensus target price of $24.83.
TRADEMARK VIOLATION NOTICE: “Cryolife Inc (CRY) Shares Bought by Penn Capital Management Co. Inc.” was first posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this story on another site, it was copied illegally and reposted in violation of international copyright and trademark laws. The correct version of this story can be viewed at https://www.com-unik.info/2018/02/20/cryolife-inc-cry-shares-bought-by-penn-capital-management-co-inc.html.
CryoLife, Inc (CryoLife) is a medical device manufacturer and processor, and is engaged in the distribution of medical devices and implantable human tissues used in cardiac surgical procedures. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as BioGlue Surgical Adhesive, BioFoam Surgical Matrix, On-X Life Technologies Holdings, Inc valves and surgical products, CardioGenesis cardiac laser therapy product line, PerClot and PhotoFix.
Want to see what other hedge funds are holding CRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cryolife Inc (NYSE:CRY).
Receive News & Ratings for Cryolife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryolife and related companies with MarketBeat.com's FREE daily email newsletter.